Advertisement
Home Tags Diabetes: Type II

Tag: Diabetes: Type II

A normal meal tolerance test -- a simplified version of the mixed meal tolerance test -- is valuable as an insulin secretion test in patients with type 2 diabetes

Normal Meal Tolerance Test Is Practical, Reliable in T2DM

But glucagon stimulation test should be used instead for patients in hyperglycemic state
The National Diabetes Prevention Program has achieved widespread implementation of the lifestyle change portion to help prevent type 2 diabetes

Promising Start for National Diabetes Prevention Program

Overall, 35.5 percent of participants achieved weight loss goal; 41.7 percent met physical activity goal
A Telemedical Lifestyle Intervention Program can improve glycemic control in advanced-stage type 2 diabetes

Telemedical Lifestyle Intervention Ups T2DM Glycemic Control

TeLiPro linked to significantly higher reduction in HbA1c in advanced-stage type 2 diabetes
The type 2 diabetes medication canagliflozin (brand names Invokana

FDA Warns of Amputation Risk Associated With Canagliflozin

Canagliflozin tied to a doubling of amputations of legs, feet, agency says
Multidisciplinary collaborative care with pharmacist follow-up is beneficial for Asian patients with uncontrolled type 2 diabetes

Pharmacist-Involved Collaborative Care Benefits T2DM

Mean reduction of HbA1c in intervention arm with multidisciplinary care and pharmacist follow-up
For patients with type 2 diabetes and vitamin D deficiency

Vitamin D Doesn’t Impact Insulin Sensitivity, Secretion in T2DM

No difference between or within groups in insulin sensitivity, glycemic control with vitamin D3, placebo
For overweight and obese adults with type 2 diabetes

Linear Association for Weight Loss, HbA1c Reduction in T2DM

Data from trials show weight loss is associated with HbA1c reduction in dose-dependent manner
For overweight and obese individuals

Cardiometabolic Disease Staging Score Quantifies Diabetes Risk

CMDS can predict the effectiveness of weight-loss therapy for preventing diabetes in overweight/obese
Subcutaneous injection of H2 significantly improves type 2 diabetes mellitus-related outcomes in a mouse model

H2 Injection Aids Diabetes Outcomes in Animal Model

Subcutaneous injection may be an effective means of administration
Patients with type 2 diabetes mellitus -- particularly those who are overweight or obese -- have decreased cortical thickness in several areas of the brain

Decreased Cortical Thickness Seen in Type 2 Diabetes

Excess weight appears to amplify the threat, researchers say